BillionToOne, Inc.·4

Jun 26, 5:20 PM ET

Sakakibara Shan Riku 4

4 · BillionToOne, Inc. · Filed Jun 26, 2026

Research Summary

AI-generated summary of this filing

Updated

BillionToOne (BLLN) CPO Sakakibara Exercises Options, Sells Shares

What Happened Sakakibara Shan Riku, Chief Product Officer of BillionToOne, exercised option-related derivatives and sold shares on June 24, 2026. The filing shows two option-related transactions of 4,000 shares each at an exercise price of $8.65 per share (reported amounts $34,600 each). Separately, Sakakibara sold two blocks of 4,000 shares in open-market transactions at $110.00 per share, generating gross proceeds of $440,000 each (total $880,000). The transactions were reported on a Form 4 filed June 26, 2026.

Key Details

  • Transaction date: 2026-06-24 (reported 2026-06-26 — timely filing).
  • Option exercise entries: 4,000 shares @ $8.65 (acquired) = $34,600; 4,000 shares @ $8.65 (derivative disposition) = $34,600.
  • Open-market sales: 4,000 shares @ $110.00 = $440,000 (two separate sales; total $880,000).
  • Footnotes: Transactions were executed under a Rule 10b5-1 trading plan adopted March 6, 2026 (F1). Options are fully vested and exercisable; underlying grant details referenced in the Form 3 filed Nov 5, 2025 (F2).
  • Shares owned after the transactions: not specified in the provided summary — see the full Form 4 for post-transaction holdings.

Context

  • Code M entries denote option exercises. The combination of exercise entries and same-day open-market sales indicates the exercised shares were sold the same day (a common cashless or immediate-sale pattern), but the filing should be consulted for exact mechanics.
  • The trades were executed under a pre-established 10b5-1 plan, which often governs scheduled insider sales and reduces the implication that sales reflect a change in sentiment. The reporting person is an officer (CPO); this is not presented as a 10% owner transaction.

Insider Transaction Report

Form 4
Period: 2026-06-24
Sakakibara Shan Riku
Chief Product Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2026-06-24$8.65/sh+4,000$34,600216,000 total
  • Sale

    Class A Common Stock

    [F1]
    2026-06-24$110.00/sh4,000$440,000212,000 total
  • Sale

    Class A Common Stock

    [F1]
    2026-06-24$110.00/sh4,000$440,000208,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    [F2]
    2026-06-24$8.65/sh4,000$34,60036,000 total
    Exercise: $8.65Exp: 2033-01-18Class A Common Stock (4,000 underlying)
Footnotes (2)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
  • [F2]The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025.
Signature
/s/ Thomas P. Lynch, Attorney-in-Fact|2026-06-26

Documents

1 file
  • 4
    wk-form4_1782508810.xmlPrimary

    FORM 4